Literature DB >> 32804502

The Essential Medicinal Chemistry of Cannabidiol (CBD).

Kathryn M Nelson1, Jonathan Bisson2,3, Gurpreet Singh1, James G Graham2,3, Shao-Nong Chen2,3, J Brent Friesen2, Jayme L Dahlin4,5, Matthias Niemitz6, Michael A Walters1, Guido F Pauli2,3.   

Abstract

This Perspective of the published essential medicinal chemistry of cannabidiol (CBD) provides evidence that the popularization of CBD-fortified or CBD-labeled health products and CBD-associated health claims lacks a rigorous scientific foundation. CBD's reputation as a cure-all puts it in the same class as other "natural" panaceas, where valid ethnobotanicals are reduced to single, purportedly active ingredients. Such reductionist approaches oversimplify useful, chemically complex mixtures in an attempt to rationalize the commercial utility of natural compounds and exploit the "natural" label. Literature evidence associates CBD with certain semiubiquitous, broadly screened, primarily plant-based substances of undocumented purity that interfere with bioassays and have a low likelihood of becoming therapeutic agents. Widespread health challenges and pandemic crises such as SARS-CoV-2 create circumstances under which scientists must be particularly vigilant about healing claims that lack solid foundational data. Herein, we offer a critical review of the published medicinal chemistry properties of CBD, as well as precise definitions of CBD-containing substances and products, distilled to reveal the essential factors that impact its development as a therapeutic agent.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32804502      PMCID: PMC7666069          DOI: 10.1021/acs.jmedchem.0c00724

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  95 in total

1.  A role for the putative cannabinoid receptor GPR55 in the islets of Langerhans.

Authors:  Silvana Y Romero-Zerbo; Alex Rafacho; Adenis Díaz-Arteaga; Juan Suárez; Ivan Quesada; Mónica Imbernon; Ruth A Ross; Carlos Dieguez; Fernando Rodríguez de Fonseca; Rubén Nogueiras; Angel Nadal; Francisco J Bermúdez-Silva
Journal:  J Endocrinol       Date:  2011-09-01       Impact factor: 4.286

2.  A phase I study to assess the effect of food on the single dose bioavailability of the THC/CBD oromucosal spray.

Authors:  C G Stott; L White; S Wright; D Wilbraham; G W Guy
Journal:  Eur J Clin Pharmacol       Date:  2012-10-04       Impact factor: 2.953

Review 3.  Rational use of plasma protein and tissue binding data in drug design.

Authors:  Xingrong Liu; Matthew Wright; Cornelis E C A Hop
Journal:  J Med Chem       Date:  2014-08-06       Impact factor: 7.446

4.  Interactions between cannabidiol and commonly used antiepileptic drugs.

Authors:  Tyler E Gaston; E Martina Bebin; Gary R Cutter; Yuliang Liu; Jerzy P Szaflarski
Journal:  Epilepsia       Date:  2017-08-06       Impact factor: 5.864

5.  GC-MS Metabolite Profile and Identification of Unusual Homologous Cannabinoids in High Potency Cannabis sativa.

Authors:  Josep Basas-Jaumandreu; F Xavier C de Las Heras
Journal:  Planta Med       Date:  2020-02-13       Impact factor: 3.352

Review 6.  Pharmacokinetics and metabolism of the plant cannabinoids, delta9-tetrahydrocannabinol, cannabidiol and cannabinol.

Authors:  M A Huestis
Journal:  Handb Exp Pharmacol       Date:  2005

7.  Evaluation of cannabinoids concentration and stability in standardized preparations of cannabis tea and cannabis oil by ultra-high performance liquid chromatography tandem mass spectrometry.

Authors:  Roberta Pacifici; Emilia Marchei; Francesco Salvatore; Luca Guandalini; Francesco Paolo Busardò; Simona Pichini
Journal:  Clin Chem Lab Med       Date:  2017-08-28       Impact factor: 3.694

Review 8.  Apparent activity in high-throughput screening: origins of compound-dependent assay interference.

Authors:  Natasha Thorne; Douglas S Auld; James Inglese
Journal:  Curr Opin Chem Biol       Date:  2010-04-22       Impact factor: 8.822

9.  Improving natural product research translation: From source to clinical trial.

Authors:  Barbara C Sorkin; Adam J Kuszak; Gregory Bloss; Naomi K Fukagawa; Freddie Ann Hoffman; Mahtab Jafari; Bruce Barrett; Paula N Brown; Frederic D Bushman; Steven J Casper; Floyd H Chilton; Christopher S Coffey; Mario G Ferruzzi; D Craig Hopp; Mairead Kiely; Daniel Lakens; John B MacMillan; David O Meltzer; Marco Pahor; Jeffrey Paul; Kathleen Pritchett-Corning; Sara K Quinney; Barbara Rehermann; Kenneth D R Setchell; Nisha S Sipes; Jacqueline M Stephens; D Lansing Taylor; Hervé Tiriac; Michael A Walters; Dan Xi; Giovanna Zappalá; Guido F Pauli
Journal:  FASEB J       Date:  2019-12-10       Impact factor: 5.834

10.  Cannabinoid interactions with ion channels and receptors.

Authors:  Abeline Rose Watkins
Journal:  Channels (Austin)       Date:  2019-12       Impact factor: 2.581

View more
  20 in total

1.  Selective Preparation and High Dynamic-Range Analysis of Cannabinoids in "CBD Oil" and Other Cannabis sativa Preparations.

Authors:  Takashi Ohtsuki; J Brent Friesen; Shao-Nong Chen; James B McAlpine; Guido F Pauli
Journal:  J Nat Prod       Date:  2022-01-06       Impact factor: 4.050

2.  Oral cannabidiol for prevention of acute and transient chemotherapy-induced peripheral neuropathy.

Authors:  Sebastian W Nielsen; Simone Dyring Hasselsteen; Helena Sylow Heilmann Dominiak; Dejan Labudovic; Lars Reiter; Susanne Oksbjerg Dalton; Jørn Herrstedt
Journal:  Support Care Cancer       Date:  2022-08-06       Impact factor: 3.359

3.  Cannabidiol (CBD) Dosing: Plasma Pharmacokinetics and Effects on Accumulation in Skeletal Muscle, Liver and Adipose Tissue.

Authors:  Robert B Child; Mark J Tallon
Journal:  Nutrients       Date:  2022-05-18       Impact factor: 6.706

4.  Cannabidiol Antiproliferative Effect in Triple-Negative Breast Cancer MDA-MB-231 Cells Is Modulated by Its Physical State and by IGF-1.

Authors:  Alessia D'Aloia; Michela Ceriani; Renata Tisi; Simone Stucchi; Elena Sacco; Barbara Costa
Journal:  Int J Mol Sci       Date:  2022-06-27       Impact factor: 6.208

5.  Phytochemical Analysis of the Methanolic Extract and Essential Oil from Leaves of Industrial Hemp Futura 75 Cultivar: Isolation of a New Cannabinoid Derivative and Biological Profile Using Computational Approaches.

Authors:  Simona De Vita; Claudia Finamore; Maria Giovanna Chini; Gabriella Saviano; Vincenzo De Felice; Simona De Marino; Gianluigi Lauro; Agostino Casapullo; Francesca Fantasma; Federico Trombetta; Giuseppe Bifulco; Maria Iorizzi
Journal:  Plants (Basel)       Date:  2022-06-24

6.  Cannabidiol and Cannabigerol Inhibit Cholangiocarcinoma Growth In Vitro via Divergent Cell Death Pathways.

Authors:  Michael J Viereckl; Kelsey Krutsinger; Aaron Apawu; Jian Gu; Bryana Cardona; Donovan Barratt; Yuyan Han
Journal:  Biomolecules       Date:  2022-06-20

7.  Regarding the Mechanisms of Promiscuous Cannabinoid Pharmacology: An Elephant Has Entered the Room.

Authors:  Peter S Cogan
Journal:  Cannabis Cannabinoid Res       Date:  2021-02-11

8.  A Comprehensive Phytochemical Analysis of Terpenes, Polyphenols and Cannabinoids, and Micromorphological Characterization of 9 Commercial Varieties of Cannabis sativa L.

Authors:  Eugenia Mazzara; Jacopo Torresi; Gelsomina Fico; Alessio Papini; Nicola Kulbaka; Stefano Dall'Acqua; Stefania Sut; Stefania Garzoli; Ahmed M Mustafa; Loredana Cappellacci; Dennis Fiorini; Filippo Maggi; Claudia Giuliani; Riccardo Petrelli
Journal:  Plants (Basel)       Date:  2022-03-27

9.  Characterisation of inverse agonism of the orphan-G protein-coupled receptor GPR52 by cannabinoid ligands Cannabidiol and O-1918.

Authors:  Lisa A Stott; Cheryl A Brighton; Jason Brown; Richard Mould; Kirstie A Bennett; Robert Newman; Heather Currinn; Flavia Autore; Alicia P Higueruelo; Benjamin G Tehan; Cliona MacSweeney; Michael A O'Brien; Steve P Watson
Journal:  Heliyon       Date:  2021-06-01

Review 10.  Potential impacts of soil microbiota manipulation on secondary metabolites production in cannabis.

Authors:  Bulbul Ahmed; Mohamed Hijri
Journal:  J Cannabis Res       Date:  2021-07-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.